“Thank you to Melanoma Focus for giving us the opportunity to update these guidelines. Its been a fantastic collaboration between patients and professionals, all with the shared aim of making a complicated subject as straightforward, accessible and user-friendly as possible.” Dr Miranda Payne, Consultant Medical Oncologist, Oxford University Hospitals NHS Trust and Chair of the Melanoma Patient Guide (MPG) project
“I wish this comprehensive information for patients starting treatment for Melanoma had been available when I was diagnosed 6 years ago. It has been written for patients to give as much up to date advice as possible.” Paul (W Sussex), Stage 4 melanoma survivor with 3 years remission
With huge thanks to BMS, MSD, Novartis, Pierre Fabre and Immunocore who each provided generous grants towards the update of our patient materials. These Pharmaceutical companies did not have any input into the content, review and development of the updated guidance. And particular thanks to Onyva the agency who has so ably supported this project.
NICE have updated their Melanoma: assessment and management guideline [NG14] on 27 July 2022. This guideline covers the assessment and management of melanoma (skin cancer) in children, young people and adults. It aims to reduce variation in practice and improve survival. Read more here.